A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
A phase 2 trial of Zolbetuximab, Oxaliplatin, Pembrolizumab, Leucovorin (folinic acid), Nivolumab and Docetaxel in gastric & gastro-oesophageal junction cancer, run by Astellas Pharma Global Development, Inc., active and no longer recruiting.
Overview
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer is a phase 2 interventional study registered as NCT03505320 by Astellas Pharma Global Development, Inc., with 143 participants enrolled, started 2018-06-29 and due to reach its primary completion in 2027-06-30. Interventions recorded: zolbetuximab, oxaliplatin, leucovorin, fluorouracil, Pembrolizumab and folinic acid.
Similar pages
not linked directly; found by shared links- TrialA Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Shares Zolbetuximab, Leucovorin (folinic acid), Astellas, Oxaliplatin and the tag pipeline.
- TrialA Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
Shares Zolbetuximab, Astellas, Oxaliplatin, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialA Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Shares Astellas, Oxaliplatin, Pembrolizumab and the tag pipeline.
- TrialSonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Shares Zolbetuximab, Oxaliplatin, Nivolumab, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialA Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
Shares Zolbetuximab, Astellas and the tag pipeline.
- TrialA Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
Shares Oxaliplatin, Nivolumab, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Leucovorin (folinic acid), Oxaliplatin and the tag pipeline.
- TrialIrinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer
Shares Leucovorin (folinic acid), Oxaliplatin and the tag pipeline.